Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine

Abstract Objective The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores in individuals with migraine. Methods Data from a cross-sectional, multicountry study were used. Individuals with episodic and chr...

Full description

Saved in:
Bibliographic Details
Published inValue in health Vol. 15; no. 3; pp. 485 - 494
Main Authors Gillard, Patrick J., PharmD, MS, Devine, Beth, PharmD, MBA, PhD, Varon, Sepideh F., PhD, Liu, Lei, Sullivan, Sean D., PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Objective The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores in individuals with migraine. Methods Data from a cross-sectional, multicountry study were used. Individuals with episodic and chronic migraine were randomly assigned to training or validation samples. Spearman's correlation coefficients between paired EuroQol five-dimensional (EQ-5D) questionnaire utility values and both Headache Impact Test (HIT-6) scores and Migraine-Specific Quality-of-Life Questionnaire version 2.1 (MSQ) domain scores (role restrictive, role preventive, and emotional function) were examined. Regression models were constructed to estimate EQ-5D questionnaire utility values from the HIT-6 score or the MSQ domain scores. Preferred algorithms were confirmed in the validation samples. Results In episodic migraine, the preferred HIT-6 and MSQ algorithms explained 22% and 25% of the variance ( R2 ) in the training samples, respectively, and had similar prediction errors (root mean square errors of 0.30). In chronic migraine, the preferred HIT-6 and MSQ algorithms explained 36% and 45% of the variance in the training samples, respectively, and had similar prediction errors (root mean square errors 0.31 and 0.29). In episodic and chronic migraine, no statistically significant differences were observed between the mean observed and the mean estimated EQ-5D questionnaire utility values for the preferred HIT-6 and MSQ algorithms in the validation samples. Conclusions The relationship between the EQ-5D questionnaire and the HIT-6 or the MSQ is adequate to use regression equations to estimate EQ-5D questionnaire utility values. The preferred HIT-6 and MSQ algorithms will be useful in estimating health-state utilities in migraine trials in which no preference-based measure is present.
AbstractList Objective: The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores in individuals with migraine. Methods: Data from a cross-sectional, multicountry study were used. Individuals with episodic and chronic migraine were randomly assigned to training or validation samples. Spearman's correlation coefficients between paired EuroQol five-dimensional (EQ-5D) questionnaire utility values and both Headache Impact Test (HIT-6) scores and Migraine-Specific Quality-of-Life Questionnaire version 2.1 (MSQ) domain scores (role restrictive, role preventive, and emotional function) were examined. Regression models were constructed to estimate EQ-5D questionnaire utility values from the HIT-6 score or the MSQ domain scores. Preferred algorithms were confirmed in the validation samples. Results: In episodic migraine, the preferred HIT-6 and MSQ algorithms explained 22% and 25% of the variance (R2) in the training samples, respectively, and had similar prediction errors (root mean square errors of 0.30). In chronic migraine, the preferred HIT-6 and MSQ algorithms explained 36% and 45% of the variance in the training samples, respectively, and had similar prediction errors (root mean square errors 0.31 and 0.29). In episodic and chronic migraine, no statistically significant differences were observed between the mean observed and the mean estimated EQ-5D questionnaire utility values for the preferred HIT-6 and MSQ algorithms in the validation samples. Conclusions: The relationship between the EQ-5D questionnaire and the HIT-6 or the MSQ is adequate to use regression equations to estimate EQ-5D questionnaire utility values. The preferred HIT-6 and MSQ algorithms will be useful in estimating health-state utilities in migraine trials in which no preference-based measure is present. Adapted from the source document.
The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores in individuals with migraine. Data from a cross-sectional, multicountry study were used. Individuals with episodic and chronic migraine were randomly assigned to training or validation samples. Spearman's correlation coefficients between paired EuroQol five-dimensional (EQ-5D) questionnaire utility values and both Headache Impact Test (HIT-6) scores and Migraine-Specific Quality-of-Life Questionnaire version 2.1 (MSQ) domain scores (role restrictive, role preventive, and emotional function) were examined. Regression models were constructed to estimate EQ-5D questionnaire utility values from the HIT-6 score or the MSQ domain scores. Preferred algorithms were confirmed in the validation samples. In episodic migraine, the preferred HIT-6 and MSQ algorithms explained 22% and 25% of the variance (R(2)) in the training samples, respectively, and had similar prediction errors (root mean square errors of 0.30). In chronic migraine, the preferred HIT-6 and MSQ algorithms explained 36% and 45% of the variance in the training samples, respectively, and had similar prediction errors (root mean square errors 0.31 and 0.29). In episodic and chronic migraine, no statistically significant differences were observed between the mean observed and the mean estimated EQ-5D questionnaire utility values for the preferred HIT-6 and MSQ algorithms in the validation samples. The relationship between the EQ-5D questionnaire and the HIT-6 or the MSQ is adequate to use regression equations to estimate EQ-5D questionnaire utility values. The preferred HIT-6 and MSQ algorithms will be useful in estimating health-state utilities in migraine trials in which no preference-based measure is present.
Abstract Objective The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores in individuals with migraine. Methods Data from a cross-sectional, multicountry study were used. Individuals with episodic and chronic migraine were randomly assigned to training or validation samples. Spearman's correlation coefficients between paired EuroQol five-dimensional (EQ-5D) questionnaire utility values and both Headache Impact Test (HIT-6) scores and Migraine-Specific Quality-of-Life Questionnaire version 2.1 (MSQ) domain scores (role restrictive, role preventive, and emotional function) were examined. Regression models were constructed to estimate EQ-5D questionnaire utility values from the HIT-6 score or the MSQ domain scores. Preferred algorithms were confirmed in the validation samples. Results In episodic migraine, the preferred HIT-6 and MSQ algorithms explained 22% and 25% of the variance ( R2 ) in the training samples, respectively, and had similar prediction errors (root mean square errors of 0.30). In chronic migraine, the preferred HIT-6 and MSQ algorithms explained 36% and 45% of the variance in the training samples, respectively, and had similar prediction errors (root mean square errors 0.31 and 0.29). In episodic and chronic migraine, no statistically significant differences were observed between the mean observed and the mean estimated EQ-5D questionnaire utility values for the preferred HIT-6 and MSQ algorithms in the validation samples. Conclusions The relationship between the EQ-5D questionnaire and the HIT-6 or the MSQ is adequate to use regression equations to estimate EQ-5D questionnaire utility values. The preferred HIT-6 and MSQ algorithms will be useful in estimating health-state utilities in migraine trials in which no preference-based measure is present.
The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores in individuals with migraine. Data from a cross-sectional, multicountry study were used. Individuals with episodic and chronic migraine were randomly assigned to training or validation samples. Spearman's correlation coefficients between paired EuroQol five-dimensional (EQ-5D) questionnaire utility values and both Headache Impact Test (HIT-6) scores and Migraine-Specific Quality-of-Life Questionnaire version 2.1 (MSQ) domain scores (role restrictive, role preventive, and emotional function) were examined. Regression models were constructed to estimate EQ-5D questionnaire utility values from the HIT-6 score or the MSQ domain scores. Preferred algorithms were confirmed in the validation samples. In episodic migraine, the preferred HIT-6 and MSQ algorithms explained 22% and 25% of the variance (R2) in the training samples, respectively, and had similar prediction errors (root mean square errors of 0.30). In chronic migraine, the preferred HIT-6 and MSQ algorithms explained 36% and 45% of the variance in the training samples, respectively, and had similar prediction errors (root mean square errors 0.31 and 0.29). In episodic and chronic migraine, no statistically significant differences were observed between the mean observed and the mean estimated EQ-5D questionnaire utility values for the preferred HIT-6 and MSQ algorithms in the validation samples. The relationship between the EQ-5D questionnaire and the HIT-6 or the MSQ is adequate to use regression equations to estimate EQ-5D questionnaire utility values. The preferred HIT-6 and MSQ algorithms will be useful in estimating health-state utilities in migraine trials in which no preference-based measure is present.
OBJECTIVEThe objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores in individuals with migraine.METHODSData from a cross-sectional, multicountry study were used. Individuals with episodic and chronic migraine were randomly assigned to training or validation samples. Spearman's correlation coefficients between paired EuroQol five-dimensional (EQ-5D) questionnaire utility values and both Headache Impact Test (HIT-6) scores and Migraine-Specific Quality-of-Life Questionnaire version 2.1 (MSQ) domain scores (role restrictive, role preventive, and emotional function) were examined. Regression models were constructed to estimate EQ-5D questionnaire utility values from the HIT-6 score or the MSQ domain scores. Preferred algorithms were confirmed in the validation samples.RESULTSIn episodic migraine, the preferred HIT-6 and MSQ algorithms explained 22% and 25% of the variance (R(2)) in the training samples, respectively, and had similar prediction errors (root mean square errors of 0.30). In chronic migraine, the preferred HIT-6 and MSQ algorithms explained 36% and 45% of the variance in the training samples, respectively, and had similar prediction errors (root mean square errors 0.31 and 0.29). In episodic and chronic migraine, no statistically significant differences were observed between the mean observed and the mean estimated EQ-5D questionnaire utility values for the preferred HIT-6 and MSQ algorithms in the validation samples.CONCLUSIONSThe relationship between the EQ-5D questionnaire and the HIT-6 or the MSQ is adequate to use regression equations to estimate EQ-5D questionnaire utility values. The preferred HIT-6 and MSQ algorithms will be useful in estimating health-state utilities in migraine trials in which no preference-based measure is present.
Author Devine, Beth, PharmD, MBA, PhD
Sullivan, Sean D., PhD
Gillard, Patrick J., PharmD, MS
Liu, Lei
Varon, Sepideh F., PhD
Author_xml – sequence: 1
  fullname: Gillard, Patrick J., PharmD, MS
– sequence: 2
  fullname: Devine, Beth, PharmD, MBA, PhD
– sequence: 3
  fullname: Varon, Sepideh F., PhD
– sequence: 4
  fullname: Liu, Lei
– sequence: 5
  fullname: Sullivan, Sean D., PhD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22583459$$D View this record in MEDLINE/PubMed
BookMark eNqNkktv1DAUhSNURB_wB1ggL9kkXNuJE0sICRX6kDpiMZSt5TjXrUMmCbYzaP49jqawYIFY-fWdI-uce56djNOIWfaaQkGBind90e_1UDCgtKCsAKifZWe0YmVe1pyfpD3IJudAq9PsPIQeAARn1YvslLGq4WUlz7J2o-fZjQ_E-mlHPrmAOmC-ndE46wzZpOPiMZA4kRvUQ3zMt1FHJPfRDS4eyDc9LOnZjeR27NzedYseAvnp4iPZuAev3Ygvs-c2XeKrp_Uiu7_6_PXyJr_7cn17-fEuN2XTxLxCsI1sJTfAuJRa1B1QbFF3trYUBeiqbhup21Jg3bYNsyUI21WyrkoNVvCL7O3Rd_bTj_SpqHYuGBwGPeK0BEWBgwReCvgPlHJJa8loQtkRNX4KwaNVs3c77Q8JWjmherXWoNYaFGUq1ZBEb578l3aH3R_J79wT8P4IYApk79CrYByOBjvn0UTVTe7f_h_-kpvBjc7o4TseMPTT4scUtaIqJIHaroOwzgFNGQjRAP8F7S2vfQ
CitedBy_id crossref_primary_10_1080_13696998_2024_2340932
crossref_primary_10_1016_j_jval_2013_11_005
crossref_primary_10_1177_0333102418796842
crossref_primary_10_1111_head_14629
crossref_primary_10_1186_s10194_024_01749_8
crossref_primary_10_1080_13696998_2019_1675417
crossref_primary_10_1080_13696998_2020_1748636
crossref_primary_10_1177_0272989X15578127
crossref_primary_10_1007_s12325_021_01897_2
crossref_primary_10_1177_0333102417731348
crossref_primary_10_1007_s12325_022_02369_x
crossref_primary_10_1016_j_jval_2018_09_2840
crossref_primary_10_1186_s12948_016_0049_9
crossref_primary_10_1186_s12955_019_1242_6
crossref_primary_10_1007_s40273_023_01288_1
crossref_primary_10_1016_j_vhri_2020_12_003
crossref_primary_10_1186_s10194_021_01378_5
crossref_primary_10_1007_s11136_021_02995_y
crossref_primary_10_1186_s12883_024_03697_x
crossref_primary_10_1007_s10198_021_01342_9
crossref_primary_10_1186_s10194_020_01162_x
crossref_primary_10_1007_s10072_014_1741_5
crossref_primary_10_1080_14737167_2023_2219898
crossref_primary_10_3111_13696998_2013_802694
crossref_primary_10_1111_head_13969
crossref_primary_10_1002_psp4_13048
crossref_primary_10_1007_s40273_020_00996_2
crossref_primary_10_1177_0272989X18756890
crossref_primary_10_1007_s11136_019_02163_3
crossref_primary_10_1080_13696998_2018_1457533
crossref_primary_10_47795_ZIWX7131
crossref_primary_10_3109_17453674_2013_865097
crossref_primary_10_1007_s40258_019_00467_6
crossref_primary_10_1007_s40276_013_0003_5
crossref_primary_10_1111_jep_12711
Cites_doi 10.1007/s10198-009-0168-z
10.1111/j.1524-4733.2008.00405.x
10.1111/j.1526-4610.2005.05183.x
10.1016/j.clinthera.2007.05.008
10.1186/1477-7525-4-14
10.1111/j.1526-4610.2011.01945.x
10.1111/j.1524-4733.2007.00195.x
10.1007/s11136-008-9392-8
10.1002/art.22885
10.1111/j.1524-4733.2007.00171.x
10.1177/0272989X09349961
10.1007/s10198-005-0309-y
10.1007/s11136-007-9206-4
10.1097/00005650-198903001-00018
10.1136/bmj.305.6845.87
10.1177/0333102410364677
10.1212/01.wnl.0000323925.29520.e7
10.3109/07853890109002087
10.1046/j.1526-4610.2003.03068.x
10.1186/1477-7525-8-141
10.1097/NMD.0b013e3181924ad8
10.1046/j.1526-4610.2000.00030.x
10.1177/0272989X05284108
10.1089/jwh.2007.0468
10.1016/S0025-6196(11)60561-2
10.1016/j.cpr.2007.01.015
10.1136/bmj.329.7472.972
10.1177/0333102410379890
10.2105/AJPH.2005.066225
10.1046/j.1526-4610.2001.041006573.x
10.1177/0333102410364676
10.1111/j.1468-2982.2006.01172.x
10.1177/0333102411410610
10.1023/A:1026119331193
10.1177/0333102410381145
10.1046/j.1526-4610.1998.3804295.x
10.1111/j.1524-4733.2004.74012.x
10.1136/jnnp.2009.192492
ContentType Journal Article
Copyright International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
– notice: 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
– notice: Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QJ
DOI 10.1016/j.jval.2011.12.007
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Applied Social Sciences Index & Abstracts (ASSIA)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Applied Social Sciences Index and Abstracts (ASSIA)
DatabaseTitleList Applied Social Sciences Index and Abstracts (ASSIA)
MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1524-4733
EndPage 494
ExternalDocumentID 10_1016_j_jval_2011_12_007
22583459
S1098301511036680
1_s2_0_S1098301511036680
Genre Validation Studies
Randomized Controlled Trial
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
--K
--M
.1-
.3N
.FO
.GA
.Y3
.~1
0R~
0SF
10A
123
1OC
1P~
1~.
29Q
31~
36B
4.4
44B
457
4G.
51W
51X
52N
52P
52R
52S
52X
53G
5LA
5VS
66C
6I.
6PF
7-5
7PT
8-1
8P~
8UM
AACTN
AAEDT
AAEDW
AAFJI
AAFTH
AAFWJ
AAHHS
AAIKJ
AAKOC
AALRI
AAOAW
AAPFB
AAQFI
AAQXK
AAWTL
AAXKI
AAXUO
ABBQC
ABCQN
ABDBF
ABEML
ABIVO
ABJNI
ABMAC
ABMMH
ABMZM
ABVKL
ABXDB
ACCFJ
ACDAQ
ACGFS
ACHQT
ACPRK
ACRLP
ACXQS
ADBBV
ADEZE
ADFHU
ADMUD
ADVLN
AEBSH
AEEZP
AEKER
AENEX
AEQDE
AEVXI
AEXQZ
AEYQN
AFBPY
AFCTW
AFEBI
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AFZJQ
AGHFR
AGTHC
AGUBO
AGYEJ
AIEXJ
AIIAU
AIKHN
AITUG
AIWBW
AJAOE
AJBDE
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AOMHK
ASPBG
AVARZ
AVWKF
AXJTR
AXLSJ
AZFZN
BAWUL
BFHJK
BKOJK
BLXMC
BNPGV
BY8
CAG
CO8
COF
CS3
DCZOG
DIK
DU5
EAD
EAP
EBS
EFJIC
EJD
EMB
EMK
EMOBN
ESX
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
HF~
HVGLF
HZI
HZ~
IHE
IXB
KOM
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OIG
OK1
OVD
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
QB0
R2-
RIG
ROL
SDF
SEL
SES
SPCBC
SSB
SSF
SSH
SSO
SSZ
SUPJJ
SV3
T5K
TEORI
TUS
W99
WYUIH
XG1
YFH
Z5R
~G-
AAIAV
ABLVK
ABYKQ
AJBFU
AKYCK
EFLBG
IXIXF
LCYCR
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QJ
ID FETCH-LOGICAL-c488t-5e0f89b93c02399a67d01ebeadf7f1e60a57b89ab46e7bb82f406fd59754a0f63
IEDL.DBID AIKHN
ISSN 1098-3015
IngestDate Fri Aug 16 22:23:45 EDT 2024
Thu Aug 15 22:21:03 EDT 2024
Thu Sep 26 15:43:53 EDT 2024
Sat Sep 28 07:51:37 EDT 2024
Fri Feb 23 02:28:25 EST 2024
Tue Oct 15 22:56:02 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords EQ-5D
mapping
episodic migraine
HIT-6
utility
MSQ
chronic migraine
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c488t-5e0f89b93c02399a67d01ebeadf7f1e60a57b89ab46e7bb82f406fd59754a0f63
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1098301511036680
PMID 22583459
PQID 1013917921
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1030903460
proquest_miscellaneous_1013917921
crossref_primary_10_1016_j_jval_2011_12_007
pubmed_primary_22583459
elsevier_sciencedirect_doi_10_1016_j_jval_2011_12_007
elsevier_clinicalkeyesjournals_1_s2_0_S1098301511036680
PublicationCentury 2000
PublicationDate 2012-05-01
PublicationDateYYYYMMDD 2012-05-01
PublicationDate_xml – month: 05
  year: 2012
  text: 2012-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Value in health
PublicationTitleAlternate Value Health
PublicationYear 2012
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Bansback, Marra, Tsuchiya (bib9) 2007; 57
Jhingran, Osterhaus, Miller (bib27) 1998; 38
Tsuchiya, Brazier, McColl (bib43) 2002
Kosinski, Bayless, Bjorner (bib26) 2003; 12
Coast (bib5) 1992; 305
Diener, Dodick, Aurora (bib32) 2010; 30
Cheung, Tan, Lau (bib8) 2008; 17
Blumenfeld, Varon, Wilcox (bib23) 2011; 31
Yang, Rendas-Baum, Varon (bib28) 2011; 31
Martin, Pathak, Sharfman (bib29) 2000; 40
Stokes, Becker, Lipton (bib24) 2011; 51
Bigal, Serrano, Reed (bib21) 2008; 71
(bib18) 2004; 24
Brazier, Yang, Tsuchiya (bib3) 2010; 11
Jiang, Hesser (bib39) 2006; 4
Buxton, Lacey, Feagan (bib11) 2007; 10
McKenzie, van der Pol (bib13) 2009; 12
Jiang, Hesser (bib35) 2009; 6
Olatunji, Cisler, Tolin (bib38) 2007; 27
Versteegh, Rowen, Brazier (bib45) 2010; 8
Payne, Varon, Kawata (bib17) 2011; 10
Buse, Manack, Serrano (bib25) 2010; 81
Strine, Hootman, Chapman (bib40) 2005; 95
Bagley, Rendas-Baum, Maglinte (bib30) 2011 Sep 19
Strine, Kroenke, Dhingra (bib36) 2009; 197
Rabin, de Charro (bib4) 2001; 33
Huang, Wilke, Atkinson (bib34) 2007; 6
Diamond, Dahlof, Papadopoulos (bib42) 2005; 45
Patrick, Deyo (bib33) 1989; 27
Taylor, Drummond, Sullivan (bib1) 2004; 329
Longworth, Buxton, Sculpher (bib6) 2005; 6
Grootendorst, Marshall, Pericak (bib10) 2007; 34
Freitag (bib15) 2007; 29
Gray, Rivero-Arias, Clarke (bib44) 2006; 26
Rivero-Arias, Ouellet, Gray (bib7) 2010; 30
Drummond, Sculpher, Torrance (bib2) 2005
Aurora, Dodick, Turkel (bib31) 2010; 30
Zahran, Kobau, Moriarty (bib41) 2005; 54
Olesen, Bousser, Diener (bib19) 2006; 26
Bigal, Rapoport, Lipton (bib20) 2003; 43
Brazier, Kolotkin, Crosby (bib12) 2004; 7
Buse, Rupnow, Lipton (bib16) 2009; 84
Meletiche, Lofland, Young (bib22) 2001; 41
Ford, Mokdad, Li (bib37) 2008; 17
Wu, Mulani, Farrell (bib14) 2007; 10
Grootendorst (10.1016/j.jval.2011.12.007_bib10) 2007; 34
Meletiche (10.1016/j.jval.2011.12.007_bib22) 2001; 41
Zahran (10.1016/j.jval.2011.12.007_bib41) 2005; 54
Yang (10.1016/j.jval.2011.12.007_bib28) 2011; 31
Diamond (10.1016/j.jval.2011.12.007_bib42) 2005; 45
Diener (10.1016/j.jval.2011.12.007_bib32) 2010; 30
Martin (10.1016/j.jval.2011.12.007_bib29) 2000; 40
Brazier (10.1016/j.jval.2011.12.007_bib12) 2004; 7
Cheung (10.1016/j.jval.2011.12.007_bib8) 2008; 17
Bigal (10.1016/j.jval.2011.12.007_bib21) 2008; 71
Taylor (10.1016/j.jval.2011.12.007_bib1) 2004; 329
Freitag (10.1016/j.jval.2011.12.007_bib15) 2007; 29
Olesen (10.1016/j.jval.2011.12.007_bib19) 2006; 26
Ford (10.1016/j.jval.2011.12.007_bib37) 2008; 17
Gray (10.1016/j.jval.2011.12.007_bib44) 2006; 26
Blumenfeld (10.1016/j.jval.2011.12.007_bib23) 2011; 31
Huang (10.1016/j.jval.2011.12.007_bib34) 2007; 6
Aurora (10.1016/j.jval.2011.12.007_bib31) 2010; 30
Strine (10.1016/j.jval.2011.12.007_bib40) 2005; 95
Jhingran (10.1016/j.jval.2011.12.007_bib27) 1998; 38
Versteegh (10.1016/j.jval.2011.12.007_bib45) 2010; 8
Bansback (10.1016/j.jval.2011.12.007_bib9) 2007; 57
Wu (10.1016/j.jval.2011.12.007_bib14) 2007; 10
Olatunji (10.1016/j.jval.2011.12.007_bib38) 2007; 27
Drummond (10.1016/j.jval.2011.12.007_bib2) 2005
(10.1016/j.jval.2011.12.007_bib18) 2004; 24
Buse (10.1016/j.jval.2011.12.007_bib16) 2009; 84
Rivero-Arias (10.1016/j.jval.2011.12.007_bib7) 2010; 30
Kosinski (10.1016/j.jval.2011.12.007_bib26) 2003; 12
Strine (10.1016/j.jval.2011.12.007_bib36) 2009; 197
Coast (10.1016/j.jval.2011.12.007_bib5) 1992; 305
Payne (10.1016/j.jval.2011.12.007_bib17) 2011; 10
Jiang (10.1016/j.jval.2011.12.007_bib39) 2006; 4
Bagley (10.1016/j.jval.2011.12.007_bib30) 2011
Longworth (10.1016/j.jval.2011.12.007_bib6) 2005; 6
Buse (10.1016/j.jval.2011.12.007_bib25) 2010; 81
Bigal (10.1016/j.jval.2011.12.007_bib20) 2003; 43
Brazier (10.1016/j.jval.2011.12.007_bib3) 2010; 11
Jiang (10.1016/j.jval.2011.12.007_bib35) 2009; 6
McKenzie (10.1016/j.jval.2011.12.007_bib13) 2009; 12
Rabin (10.1016/j.jval.2011.12.007_bib4) 2001; 33
Stokes (10.1016/j.jval.2011.12.007_bib24) 2011; 51
Buxton (10.1016/j.jval.2011.12.007_bib11) 2007; 10
Tsuchiya (10.1016/j.jval.2011.12.007_bib43) 2002
Patrick (10.1016/j.jval.2011.12.007_bib33) 1989; 27
References_xml – year: 2005
  ident: bib2
  article-title: Methods for the Economic Evaluation of Health Care Programmes
  contributor:
    fullname: Torrance
– volume: 41
  start-page: 573
  year: 2001
  end-page: 578
  ident: bib22
  article-title: Quality-of-life differences between patients with episodic and transformed migraine
  publication-title: Headache
  contributor:
    fullname: Young
– volume: 40
  start-page: 204
  year: 2000
  end-page: 215
  ident: bib29
  article-title: Validity and reliability of the migraine-specific quality of life questionnaire
  publication-title: Headache
  contributor:
    fullname: Sharfman
– volume: 17
  start-page: 1173
  year: 2008
  end-page: 1181
  ident: bib8
  article-title: Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index
  publication-title: Qual Life Res
  contributor:
    fullname: Lau
– volume: 26
  start-page: 742
  year: 2006
  end-page: 746
  ident: bib19
  article-title: New appendix criteria open for a broader concept of chronic migraine
  publication-title: Cephalalgia
  contributor:
    fullname: Diener
– volume: 57
  start-page: 963
  year: 2007
  end-page: 971
  ident: bib9
  article-title: Using the Health Assessment Questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis
  publication-title: Arthritis Care Res
  contributor:
    fullname: Tsuchiya
– volume: 10
  start-page: 1116
  year: 2011
  end-page: 1130
  ident: bib17
  article-title: The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics
  publication-title: Cephalalgia
  contributor:
    fullname: Kawata
– volume: 34
  start-page: 534
  year: 2007
  end-page: 542
  ident: bib10
  article-title: A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in the patients with osteoarthritis of the knee
  publication-title: J Rheumatol
  contributor:
    fullname: Pericak
– volume: 6
  start-page: A30
  year: 2009
  ident: bib35
  article-title: Using item response theory to analyze the relationship between health-related quality of life and health risk factors
  publication-title: Prev Chronic Dis
  contributor:
    fullname: Hesser
– volume: 38
  start-page: 295
  year: 1998
  end-page: 302
  ident: bib27
  article-title: Development and validation of the Migraine-Specific Quality of Life Questionnaire
  publication-title: Headache
  contributor:
    fullname: Miller
– volume: 31
  start-page: 357
  year: 2011
  end-page: 367
  ident: bib28
  article-title: Validation of the Headache Impact Test (HIT-6) across episodic and chronic migraine
  publication-title: Cephalalgia
  contributor:
    fullname: Varon
– volume: 305
  start-page: 87
  year: 1992
  end-page: 90
  ident: bib5
  article-title: Reprocessing data to form QALYs
  publication-title: BMJ
  contributor:
    fullname: Coast
– volume: 10
  start-page: 214
  year: 2007
  end-page: 220
  ident: bib11
  article-title: Mapping from disease-specific measures to utility: an analysis of the relationship between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility
  publication-title: Value Health
  contributor:
    fullname: Feagan
– volume: 43
  start-page: 336
  year: 2003
  end-page: 342
  ident: bib20
  article-title: Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine
  publication-title: Headache
  contributor:
    fullname: Lipton
– volume: 11
  start-page: 215
  year: 2010
  end-page: 225
  ident: bib3
  article-title: A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures
  publication-title: Eur J Health Econ
  contributor:
    fullname: Tsuchiya
– volume: 71
  start-page: 559
  year: 2008
  end-page: 566
  ident: bib21
  article-title: Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment
  publication-title: Neurology
  contributor:
    fullname: Reed
– volume: 197
  start-page: 61
  year: 2009
  end-page: 64
  ident: bib36
  article-title: The associations between depression, health-related quality of life, social support, life satisfaction, and disability in community-dwelling US adults
  publication-title: J Nerv Ment Dis
  contributor:
    fullname: Dhingra
– volume: 54
  start-page: 1
  year: 2005
  end-page: 35
  ident: bib41
  article-title: Health-related quality of life surveillance—United States, 1993–2002
  publication-title: MMWR Surveill Summ
  contributor:
    fullname: Moriarty
– volume: 27
  start-page: S217
  year: 1989
  end-page: S232
  ident: bib33
  article-title: Generic and disease-specific measures in assessing health status and quality of life
  publication-title: Med Car
  contributor:
    fullname: Deyo
– volume: 84
  start-page: 422
  year: 2009
  end-page: 435
  ident: bib16
  article-title: Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life
  publication-title: Mayo Clin Proc
  contributor:
    fullname: Lipton
– volume: 4
  start-page: 1
  year: 2006
  end-page: 10
  ident: bib39
  article-title: Associations between health-related quality of life and demographics and health risks
  publication-title: Health Qual Life Outcomes
  contributor:
    fullname: Hesser
– volume: 30
  start-page: 341
  year: 2010
  end-page: 354
  ident: bib7
  article-title: Mapping the modified Rankin Scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome
  publication-title: Med Decis Making
  contributor:
    fullname: Gray
– volume: 17
  start-page: 757
  year: 2008
  end-page: 768
  ident: bib37
  article-title: Gender differences in coronary heart disease and health-related quality of life: findings from 10 states from the 2004 behavioral risk factor surveillance system
  publication-title: J Womens Health (Larchmt)
  contributor:
    fullname: Li
– volume: 7
  start-page: 484
  year: 2004
  end-page: 496
  ident: bib12
  article-title: Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D
  publication-title: Value Health
  contributor:
    fullname: Crosby
– volume: 33
  start-page: 337
  year: 2001
  end-page: 343
  ident: bib4
  article-title: EQ-5D: a measure of health status from the EuroQol Group
  publication-title: Ann Med
  contributor:
    fullname: de Charro
– volume: 51
  start-page: 1058
  year: 2011
  end-page: 1077
  ident: bib24
  article-title: Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS)
  publication-title: Headache
  contributor:
    fullname: Lipton
– volume: 30
  start-page: 804
  year: 2010
  ident: bib32
  article-title: OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
  publication-title: Cephalalgia
  contributor:
    fullname: Aurora
– volume: 95
  start-page: 2042
  year: 2005
  end-page: 2048
  ident: bib40
  article-title: Health-related quality of life, health risk behaviors, and disability among adults with pain-related activity difficulty
  publication-title: Am J Public Health
  contributor:
    fullname: Chapman
– volume: 12
  start-page: 963
  year: 2003
  end-page: 974
  ident: bib26
  article-title: A six-item short-form survey for measuring headache impact: the HIT-6
  publication-title: Qual Life Res
  contributor:
    fullname: Bjorner
– year: 2002
  ident: bib43
  article-title: Deriving Preference-Based Single Indices from Non-preference Based Condition Specific Instruments: converting AQLQ into EQ-5D Indices
  contributor:
    fullname: McColl
– volume: 31
  start-page: 301
  year: 2011
  end-page: 315
  ident: bib23
  article-title: Disability, HRQoL, and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)
  publication-title: Cephalalgia
  contributor:
    fullname: Wilcox
– volume: 30
  start-page: 793
  year: 2010
  ident: bib31
  article-title: OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
  publication-title: Cephalalgia
  contributor:
    fullname: Turkel
– volume: 10
  start-page: 408
  year: 2007
  end-page: 414
  ident: bib14
  article-title: Mapping FACT-P and EORTC QLQ C-30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients
  publication-title: Value Health
  contributor:
    fullname: Farrell
– volume: 45
  start-page: 1023
  year: 2005
  end-page: 1030
  ident: bib42
  article-title: Topiramate improves HRQOL when used to prevent migraines
  publication-title: Headache
  contributor:
    fullname: Papadopoulos
– volume: 329
  start-page: 972
  year: 2004
  end-page: 975
  ident: bib1
  article-title: Inclusion of cost-effectiveness in licensing requirements of new drugs: the fourth hurdle
  publication-title: BMJ
  contributor:
    fullname: Sullivan
– volume: 81
  start-page: 428
  year: 2010
  end-page: 432
  ident: bib25
  article-title: Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
  publication-title: J Neurol Neurosurg Psychiatry
  contributor:
    fullname: Serrano
– volume: 26
  start-page: 18
  year: 2006
  end-page: 29
  ident: bib44
  article-title: Estimating the association between SF-12 responses and EQ-5D utility values by response mapping
  publication-title: Med Decis Making
  contributor:
    fullname: Clarke
– volume: 6
  start-page: 347
  year: 2005
  end-page: 353
  ident: bib6
  article-title: Estimating utility data from clinical indicators for patients with stable angina
  publication-title: Eur J Health Econ
  contributor:
    fullname: Sculpher
– year: 2011 Sep 19
  ident: bib30
  article-title: Validating migraine-specific quality of life questionnaire v2.1 in episodic and chronic migraine
  publication-title: Headache
  contributor:
    fullname: Maglinte
– volume: 29
  start-page: 939
  year: 2007
  end-page: 949
  ident: bib15
  article-title: The cycle of migraine: patients' quality of life during and between migraine attacks
  publication-title: Clin Ther
  contributor:
    fullname: Freitag
– volume: 12
  start-page: 167
  year: 2009
  end-page: 171
  ident: bib13
  article-title: Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data
  publication-title: Value Health
  contributor:
    fullname: van der Pol
– volume: 8
  start-page: 141
  year: 2010
  ident: bib45
  article-title: Mapping onto EQ-5 D for patients in poor health
  publication-title: Health Qual Life Outcomes
  contributor:
    fullname: Brazier
– volume: 24
  start-page: 9
  year: 2004
  end-page: 160
  ident: bib18
  article-title: The International Classification of Headache Disorders: 2nd edition
  publication-title: Cephalalgia
– volume: 6
  start-page: 1065
  year: 2007
  end-page: 1072
  ident: bib34
  article-title: US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
  publication-title: Qual Life Res
  contributor:
    fullname: Atkinson
– volume: 27
  start-page: 572
  year: 2007
  end-page: 581
  ident: bib38
  article-title: Quality of life in the anxiety disorders: a meta-analytic review
  publication-title: Clin Psychol Rev
  contributor:
    fullname: Tolin
– volume: 11
  start-page: 215
  year: 2010
  ident: 10.1016/j.jval.2011.12.007_bib3
  article-title: A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures
  publication-title: Eur J Health Econ
  doi: 10.1007/s10198-009-0168-z
  contributor:
    fullname: Brazier
– volume: 12
  start-page: 167
  year: 2009
  ident: 10.1016/j.jval.2011.12.007_bib13
  article-title: Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2008.00405.x
  contributor:
    fullname: McKenzie
– volume: 45
  start-page: 1023
  year: 2005
  ident: 10.1016/j.jval.2011.12.007_bib42
  article-title: Topiramate improves HRQOL when used to prevent migraines
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2005.05183.x
  contributor:
    fullname: Diamond
– volume: 29
  start-page: 939
  year: 2007
  ident: 10.1016/j.jval.2011.12.007_bib15
  article-title: The cycle of migraine: patients' quality of life during and between migraine attacks
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2007.05.008
  contributor:
    fullname: Freitag
– volume: 4
  start-page: 1
  year: 2006
  ident: 10.1016/j.jval.2011.12.007_bib39
  article-title: Associations between health-related quality of life and demographics and health risks
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-4-14
  contributor:
    fullname: Jiang
– volume: 51
  start-page: 1058
  year: 2011
  ident: 10.1016/j.jval.2011.12.007_bib24
  article-title: Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS)
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2011.01945.x
  contributor:
    fullname: Stokes
– volume: 10
  start-page: 408
  year: 2007
  ident: 10.1016/j.jval.2011.12.007_bib14
  article-title: Mapping FACT-P and EORTC QLQ C-30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2007.00195.x
  contributor:
    fullname: Wu
– volume: 17
  start-page: 1173
  year: 2008
  ident: 10.1016/j.jval.2011.12.007_bib8
  article-title: Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index
  publication-title: Qual Life Res
  doi: 10.1007/s11136-008-9392-8
  contributor:
    fullname: Cheung
– volume: 57
  start-page: 963
  year: 2007
  ident: 10.1016/j.jval.2011.12.007_bib9
  article-title: Using the Health Assessment Questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis
  publication-title: Arthritis Care Res
  doi: 10.1002/art.22885
  contributor:
    fullname: Bansback
– volume: 10
  start-page: 214
  year: 2007
  ident: 10.1016/j.jval.2011.12.007_bib11
  article-title: Mapping from disease-specific measures to utility: an analysis of the relationship between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2007.00171.x
  contributor:
    fullname: Buxton
– volume: 24
  start-page: 9
  issue: Suppl. 1
  year: 2004
  ident: 10.1016/j.jval.2011.12.007_bib18
  article-title: The International Classification of Headache Disorders: 2nd edition
  publication-title: Cephalalgia
– volume: 30
  start-page: 341
  year: 2010
  ident: 10.1016/j.jval.2011.12.007_bib7
  article-title: Mapping the modified Rankin Scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome
  publication-title: Med Decis Making
  doi: 10.1177/0272989X09349961
  contributor:
    fullname: Rivero-Arias
– volume: 6
  start-page: 347
  year: 2005
  ident: 10.1016/j.jval.2011.12.007_bib6
  article-title: Estimating utility data from clinical indicators for patients with stable angina
  publication-title: Eur J Health Econ
  doi: 10.1007/s10198-005-0309-y
  contributor:
    fullname: Longworth
– volume: 6
  start-page: 1065
  year: 2007
  ident: 10.1016/j.jval.2011.12.007_bib34
  article-title: US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
  publication-title: Qual Life Res
  doi: 10.1007/s11136-007-9206-4
  contributor:
    fullname: Huang
– volume: 6
  start-page: A30
  year: 2009
  ident: 10.1016/j.jval.2011.12.007_bib35
  article-title: Using item response theory to analyze the relationship between health-related quality of life and health risk factors
  publication-title: Prev Chronic Dis
  contributor:
    fullname: Jiang
– volume: 34
  start-page: 534
  year: 2007
  ident: 10.1016/j.jval.2011.12.007_bib10
  article-title: A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in the patients with osteoarthritis of the knee
  publication-title: J Rheumatol
  contributor:
    fullname: Grootendorst
– volume: 27
  start-page: S217
  year: 1989
  ident: 10.1016/j.jval.2011.12.007_bib33
  article-title: Generic and disease-specific measures in assessing health status and quality of life
  publication-title: Med Car
  doi: 10.1097/00005650-198903001-00018
  contributor:
    fullname: Patrick
– volume: 305
  start-page: 87
  year: 1992
  ident: 10.1016/j.jval.2011.12.007_bib5
  article-title: Reprocessing data to form QALYs
  publication-title: BMJ
  doi: 10.1136/bmj.305.6845.87
  contributor:
    fullname: Coast
– volume: 30
  start-page: 804
  year: 2010
  ident: 10.1016/j.jval.2011.12.007_bib32
  article-title: OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
  publication-title: Cephalalgia
  doi: 10.1177/0333102410364677
  contributor:
    fullname: Diener
– volume: 71
  start-page: 559
  year: 2008
  ident: 10.1016/j.jval.2011.12.007_bib21
  article-title: Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000323925.29520.e7
  contributor:
    fullname: Bigal
– volume: 33
  start-page: 337
  year: 2001
  ident: 10.1016/j.jval.2011.12.007_bib4
  article-title: EQ-5D: a measure of health status from the EuroQol Group
  publication-title: Ann Med
  doi: 10.3109/07853890109002087
  contributor:
    fullname: Rabin
– volume: 43
  start-page: 336
  year: 2003
  ident: 10.1016/j.jval.2011.12.007_bib20
  article-title: Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine
  publication-title: Headache
  doi: 10.1046/j.1526-4610.2003.03068.x
  contributor:
    fullname: Bigal
– volume: 8
  start-page: 141
  year: 2010
  ident: 10.1016/j.jval.2011.12.007_bib45
  article-title: Mapping onto EQ-5 D for patients in poor health
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-8-141
  contributor:
    fullname: Versteegh
– volume: 197
  start-page: 61
  year: 2009
  ident: 10.1016/j.jval.2011.12.007_bib36
  article-title: The associations between depression, health-related quality of life, social support, life satisfaction, and disability in community-dwelling US adults
  publication-title: J Nerv Ment Dis
  doi: 10.1097/NMD.0b013e3181924ad8
  contributor:
    fullname: Strine
– volume: 40
  start-page: 204
  year: 2000
  ident: 10.1016/j.jval.2011.12.007_bib29
  article-title: Validity and reliability of the migraine-specific quality of life questionnaire
  publication-title: Headache
  doi: 10.1046/j.1526-4610.2000.00030.x
  contributor:
    fullname: Martin
– year: 2005
  ident: 10.1016/j.jval.2011.12.007_bib2
  contributor:
    fullname: Drummond
– volume: 26
  start-page: 18
  year: 2006
  ident: 10.1016/j.jval.2011.12.007_bib44
  article-title: Estimating the association between SF-12 responses and EQ-5D utility values by response mapping
  publication-title: Med Decis Making
  doi: 10.1177/0272989X05284108
  contributor:
    fullname: Gray
– volume: 17
  start-page: 757
  year: 2008
  ident: 10.1016/j.jval.2011.12.007_bib37
  article-title: Gender differences in coronary heart disease and health-related quality of life: findings from 10 states from the 2004 behavioral risk factor surveillance system
  publication-title: J Womens Health (Larchmt)
  doi: 10.1089/jwh.2007.0468
  contributor:
    fullname: Ford
– volume: 84
  start-page: 422
  year: 2009
  ident: 10.1016/j.jval.2011.12.007_bib16
  article-title: Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life
  publication-title: Mayo Clin Proc
  doi: 10.1016/S0025-6196(11)60561-2
  contributor:
    fullname: Buse
– volume: 27
  start-page: 572
  year: 2007
  ident: 10.1016/j.jval.2011.12.007_bib38
  article-title: Quality of life in the anxiety disorders: a meta-analytic review
  publication-title: Clin Psychol Rev
  doi: 10.1016/j.cpr.2007.01.015
  contributor:
    fullname: Olatunji
– volume: 329
  start-page: 972
  year: 2004
  ident: 10.1016/j.jval.2011.12.007_bib1
  article-title: Inclusion of cost-effectiveness in licensing requirements of new drugs: the fourth hurdle
  publication-title: BMJ
  doi: 10.1136/bmj.329.7472.972
  contributor:
    fullname: Taylor
– year: 2002
  ident: 10.1016/j.jval.2011.12.007_bib43
  contributor:
    fullname: Tsuchiya
– volume: 54
  start-page: 1
  year: 2005
  ident: 10.1016/j.jval.2011.12.007_bib41
  article-title: Health-related quality of life surveillance—United States, 1993–2002
  publication-title: MMWR Surveill Summ
  contributor:
    fullname: Zahran
– volume: 31
  start-page: 357
  year: 2011
  ident: 10.1016/j.jval.2011.12.007_bib28
  article-title: Validation of the Headache Impact Test (HIT-6) across episodic and chronic migraine
  publication-title: Cephalalgia
  doi: 10.1177/0333102410379890
  contributor:
    fullname: Yang
– volume: 95
  start-page: 2042
  year: 2005
  ident: 10.1016/j.jval.2011.12.007_bib40
  article-title: Health-related quality of life, health risk behaviors, and disability among adults with pain-related activity difficulty
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.2005.066225
  contributor:
    fullname: Strine
– volume: 41
  start-page: 573
  year: 2001
  ident: 10.1016/j.jval.2011.12.007_bib22
  article-title: Quality-of-life differences between patients with episodic and transformed migraine
  publication-title: Headache
  doi: 10.1046/j.1526-4610.2001.041006573.x
  contributor:
    fullname: Meletiche
– year: 2011
  ident: 10.1016/j.jval.2011.12.007_bib30
  article-title: Validating migraine-specific quality of life questionnaire v2.1 in episodic and chronic migraine
  publication-title: Headache
  contributor:
    fullname: Bagley
– volume: 30
  start-page: 793
  year: 2010
  ident: 10.1016/j.jval.2011.12.007_bib31
  article-title: OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
  publication-title: Cephalalgia
  doi: 10.1177/0333102410364676
  contributor:
    fullname: Aurora
– volume: 26
  start-page: 742
  issue: 6
  year: 2006
  ident: 10.1016/j.jval.2011.12.007_bib19
  article-title: New appendix criteria open for a broader concept of chronic migraine
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2006.01172.x
  contributor:
    fullname: Olesen
– volume: 10
  start-page: 1116
  year: 2011
  ident: 10.1016/j.jval.2011.12.007_bib17
  article-title: The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics
  publication-title: Cephalalgia
  doi: 10.1177/0333102411410610
  contributor:
    fullname: Payne
– volume: 12
  start-page: 963
  year: 2003
  ident: 10.1016/j.jval.2011.12.007_bib26
  article-title: A six-item short-form survey for measuring headache impact: the HIT-6
  publication-title: Qual Life Res
  doi: 10.1023/A:1026119331193
  contributor:
    fullname: Kosinski
– volume: 31
  start-page: 301
  year: 2011
  ident: 10.1016/j.jval.2011.12.007_bib23
  article-title: Disability, HRQoL, and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)
  publication-title: Cephalalgia
  doi: 10.1177/0333102410381145
  contributor:
    fullname: Blumenfeld
– volume: 38
  start-page: 295
  year: 1998
  ident: 10.1016/j.jval.2011.12.007_bib27
  article-title: Development and validation of the Migraine-Specific Quality of Life Questionnaire
  publication-title: Headache
  doi: 10.1046/j.1526-4610.1998.3804295.x
  contributor:
    fullname: Jhingran
– volume: 7
  start-page: 484
  year: 2004
  ident: 10.1016/j.jval.2011.12.007_bib12
  article-title: Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2004.74012.x
  contributor:
    fullname: Brazier
– volume: 81
  start-page: 428
  year: 2010
  ident: 10.1016/j.jval.2011.12.007_bib25
  article-title: Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2009.192492
  contributor:
    fullname: Buse
SSID ssj0006325
Score 2.2203252
Snippet Abstract Objective The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific...
The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores in...
OBJECTIVEThe objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life scores...
Objective: The objective of this study was to develop empirical algorithms that estimate health-state utility values from disease-specific quality-of-life...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 485
SubjectTerms Adult
Algorithms
chronic migraine
Correlation coefficients
episodic migraine
EQ-5D
Female
Health Status
HIT-6
Humans
Internal Medicine
Male
Mapping
Middle Aged
Migraine
Migraine Disorders - psychology
MSQ
Quality of Life
Regression Analysis
Surveys and Questionnaires
United States
utility
Validation
Young Adult
Title Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1098301511036680
https://dx.doi.org/10.1016/j.jval.2011.12.007
https://www.ncbi.nlm.nih.gov/pubmed/22583459
https://search.proquest.com/docview/1013917921
https://search.proquest.com/docview/1030903460
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELboIlW9VIU-WNquXKniUtxNNo4fRx5Fu6VBSGXR3iw7cVBQlUUkHPbS395x7CyqoBx6jGXLjufh8Xi-GYQ-uwrRloqCcJpyQi2lBHQeIyZhDHiG06Ir95adsemcfl-kiw101GNhXFhl0P1ep3faOrSMw26Ob6pq_DOOpAD2BIsBtDATcG_fhOOI0gHaPJidTs_WCpklXe1V15-4AQE748O8roGgPpOn8wq6qrKPn0__sj-7c-jkFXoZDEh84Ne4hTZsvY2eZ-GJfBvtnftk1Kt9fHGPrWr28R4-v09TvXqNTKZdboYr7BAm-Ng_1JCuHn1Z5TjzzsMGt0vssUqkM0zxvHXhtCt8qX_BQnFV49ka1NVg59fFWXXlKk_YN2h-8u3iaEpCxQWSgyC3JLVRKaSRSd5hXjXjRRQDmXVR8jK2LNIpN0JqQ5nlxohJCfZAWcClJKU6KlnyFg3qZW13EGZSUJPbknIwelhhtMxz67LdMMkLwYsh-tLvs7rxiTVUH3F2rRxVlKOKiicKqDJEvCeF6iGjoORsEySuUbFqoKd6wBVDlK5H_sVYCs6MJ2f81FNcgcS5ZxRd2-Vd4wYkcMmVk_ipPolzgFEG87_z7LL-S9CgIqGp3P3Plb1HL-Br4qMuP6BBe3tnP4Jl1JoRevb1dzwC_j-8PP0xCnIArbPF4R9nOg3X
link.rule.ids 315,786,790,3525,4521,24144,27600,27955,27956,45618,45696,45712,45907
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQIuCMqjy9NIqBdqbbJxbOcIhWoLTVWJXbQ3y06cKhXKViQ97L9nJk62QkAPXBNbcTwPz4znmwF4Rx2ivdAlVyJVXHghOOo8yV0iJfKMEmXf7i0_k_Ol-LJKVztwNGJhKK1y0P1Bp_faengyHXZzelXX029xlGlkT7QYUAtLjX77HZGir0covtXHrTqWSd95lUZzGj4gZ0KS1yWSM9TxpJgg9ZT9--n0L-uzP4WOH8KDwXxkH8IKH8GOb_bgbj5ckO_BwXkoRb05ZIsbZFV7yA7Y-U2R6s1jcLmlygwXjPAl7FO4puF9N_qqLlgeQoct69YsIJV4b5ayZUfJtBv23f7AhbK6YSdbSFfLKKrL8vqC-k74J7A8_rw4mvOh3wIvUIw7nvqo0pnLkqJHvFqpyihGItuyUlXsZWRT5XRmnZBeOadnFVoDVYkuSSpsVMnkKew268bvA5OZFq7wlVBo8sjS2awoPNW6kZkqtSon8H7cZ3MVymqYMd_s0hBVDFHFxDODVJmAGklhRsAoqjjfDvLWmti0ONL8wRMTSLczf2MrgyfGrV98O1LcoLzRJYpt_Pq6pQkJurjZLL5tTELhLyHx-88Cu2z_EvWnTpBPn__nyt7AvfkiPzWnJ2dfX8B9fDML-ZcvYbf7ee1foY3Uude9DPwCMQAMIg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mapping+from+Disease-Specific+Measures+to+Health-State+Utility+Values+in+Individuals+with+Migraine&rft.jtitle=Value+in+health&rft.au=Gillard%2C+Patrick+J.&rft.au=Devine%2C+Beth&rft.au=Varon%2C+Sepideh+F.&rft.au=Liu%2C+Lei&rft.date=2012-05-01&rft.issn=1098-3015&rft.volume=15&rft.issue=3&rft.spage=485&rft.epage=494&rft_id=info:doi/10.1016%2Fj.jval.2011.12.007&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jval_2011_12_007
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10983015%2FS1098301512X00032%2Fcov150h.gif